Development

Ranga Velagaleti is the manager of laboratory and stability at BASF Corporation, 8800 Line Ave., Shreveport, LA 71106, tel. 318.861.8040, fax 318.861.8004, velagar1@basf-corp.com

Christopher C. DeMerlis is a regulatory affairs manager at Colorcon, a division of Berwind Pharmaceutical Services, Inc., 415 Moyer Blvd., West Point, PA 19486, tel. 215.661.2766, fax 215.661.2778.

William Brock, PhD, is principal of Brock Scientific Consulting.

Robert Osterberg, PhD, is a senior consultant of pharmacology/toxicology at Aclairo PDG.

Articles

The authors, representing the International Pharmaceutical Excipients Council, propose a new evaluation procedure, including tiered toxicology testing for excipients.

Regulatory Update: The IPEC Novel Excipient Safety Evaluation Procedure

Michelle Hoffman, editorial director of Pharmaceutical Technology.

Targeting Therapeutics for the Middle and Inner Ear

Stephanie Sutton was an assistant editor at Pharmaceutical Technology Europe.

Cargill has recently announced a number of innovations connected to its range of polyol excipients.

Cargill updates industry on portfolio innovations

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

The House Energy and Commerce Committee approved H.R. 2868, the "Chemical Facility Anti-Terrorism Act of 2009," a measure to modify and codify existing requirements of the Chemical Facility Anti-Terrorism Standards (CFATS) program.

House Committee Passes IST Requirements in Chemical Facility Security Bill

Also, Astellas and Medivation sign development pact; WuXi PharmaTech appoints VP of business development, more...

Week of Oct. 26, 2009: OXiGENE to Acquire VaxGen; Warner Chilcott Appoints Global R&D President; More...

The global API market has expanded from $69 billion in 2004 to more than $90 billion in 2008, according to a report from the Italian Chemical Pharmaceutical Association (CPA); in particular, the report noted a rapid growth rate for generic APIs.

Generic APIs Outstrip Innovation

Company and People Notes: SurModics forms agreement with Roche and Genentech; Hospira names Daphne Jones senior VP and chief information officer; more...

Week of Oct. 19, 2009: Lonza Drops Bid for Patheon; Peregrine Appoints Head of Regulatory Affairs; More...

Following the completion of its $68-billion acquisition of Wyeth (Madison, NJ), Pfizer (New York) began joint operations of the combined company last week.

Pfizer and Wyeth Begin Operations as a Combined Company

The European Fine Chemicals Group (EFCG) gave an update of some of its activities at a press conference held at CPhI Worldwide (Spain) last week, and revealed some disturbing facts regarding counterfeit APIs, which the group is particularly concerned about.

EFCG: Counterfeit Medicines More Profitable than Heroin

Company and People Notes: Bayer Schering Pharma forms collaboration with Compugen; Takeda San Francisco appoints VP of process science; more...

Ingredients